Richard Scheyer

Richard Scheyer has a diverse and extensive work experience in the medical and scientific field. Richard started in 1991 as an Associate Professor of Neurology at Yale University School of Medicine. Richard then worked at Aventis as the Director of CNS Clinical Pharmacology from 1997 to 2004. From 2004 to 2005, they held the position of Senior Director and Global Project Team Leader at sanofi-aventis. Richard then joined Daiichi Sankyo in 2006 as the Executive Director of Translational Clinical Science, where they stayed until 2013. During this time, they also served as the President and Chief Scientific Officer at in vivo veritas. In 2013, they became the Vice President and Chief Medical Officer at Neurotrope Bioscience, Inc., and in the same year, they also started working at Medpace as the VP Medical. Richard has been serving on the Advisory Board of Rutgers University since 2018. Richard Scheyer's work experience is characterized by their contributions to medical research, clinical development, and leadership in the industry.

Richard Scheyer completed their education with the following timeline:

- From 1988 to 1991, they attended the Yale University School of Medicine as a Fellow, specializing in Epilepsy and Clinical Pharmacology.

- Prior to that, from 1985 to 1988, they were a Resident in Neurology at the Yale University School of Medicine.

- Richard earned their MD degree from the State University of New York Upstate Medical University between 1980 and 1984.

- Richard began their undergraduate studies at Stanford University in 1976, majoring in Physics, and obtained their BS degree in 1980.

- Richard completed their previous education at Phillips Exeter Academy, attending from 1974 to 1976.